Within the EU, it is necessary that all investigational and medicinal products manufactured or imported by organisations holding a MA IMP, must have a 'qualified person' to approve and release each batch of IMP for usage in clinical trials.
Click here to find out more.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
